ADMA BIOLOGICS, INC. Proceeds from Issuance or Sale of Equity
ADMA BIOLOGICS, INC. (ADMA) reported Proceeds from Issuance or Sale of Equity of $42.94 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-11-09
- ADMA BIOLOGICS, INC. proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was -$1.28K.
- ADMA BIOLOGICS, INC. proceeds from issuance or sale of equity for the quarter ending 2017-09-30 was $0.00.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month |
|---|---|---|---|
| 2018-09-30 | -$1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $42.94M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $42.95M 10-Q · filed 2018-08-10 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |